NFE2L2 and neurodegenerative disease: Hispolon mitigates oxidative damage-induced cell death in PC12 cells by activating Nrf2-regulated antioxidant genes in a dose-dependent manner, positioning it as an effective activator of Nrf2 and a promising candidate for the treatment of neurodegenerative diseases (Peng et al., 2022).